CytoMed Therapeutics (GDTC) EPS (Diluted) (2022 - 2025)
CytoMed Therapeutics (GDTC) EPS (Diluted) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 0.15 |
| 10 | CytoMed Therapeutics | 9.97 Mn | 8.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.62 |
| Dec 31, 2024 | 0.78 |
| Jun 30, 2024 | 0.96 |
| Dec 31, 2023 | 1.06 |
| Jun 30, 2023 | 1.66 |
| Dec 31, 2022 | 0.07 |
| Jun 30, 2022 | 0.00 |